The Latest from the Lab


Sept 2012

Advanced Microbiological Testing and Research





July 2011

Announcing Improvement in the Expanded Female Hormone Panel™ (eFHP™)

The Expanded Female Hormone Panel™ (eFHP™) adds evaluations of the pituitary hormones, follicle stimulating hormone (FSH) and lutenizing hormone (LH), to the regular FHP™ for cycling women. Currently, five assessments of each hormone are reported, centered around the estimated time of ovulation. These assessments are valuable adjuncts in assessing a woman’s cycle for fertility and ovulation. Considering variations in the timing of ovulation and the length the cycles exist, and they may not be covered by or included in the current five reported hormone values, Diagnos-Techs™ will soon increase the number of values of FSH and LH reported to the seven middle values. This improvement will provide a broader coverage of FSH and LH values to further elucidate any vagaries encountered in a woman’s cycle.

August 2010

The following changes were implemented on some of our tests and panels.

Revision to Reference Ranges for Estradiol (E2) and Testosterone (TTF) for Women

As of August 28, 2010, Diagnos-Techs updated reference ranges for testosterone and estradiol using more advanced salivary tests. New reference ranges have been established according to the latest CLSI (Clinical Laboratory Standards Institute) guidelines.

Addition of Estradiol (E2) to Male Hormone Panels

Beginning August 20, 2010, Diagnos-Techs added estradiol (E2) to both regular and expanded Male Hormone Panels without change to the current test fees. This will provide additional insight to total estrogenic effects on prostate, breast tissue, libido and body mass composition.

If you have any questions or concerns, please contact Medical Support at 1.800.878.3787 to talk to one of our medical advisors.